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INTRODUCTION
Replantation of a completely amputated ear without microsur-
gery is a possible reconstructive modality in the absence of 
proper vessels for microsurgical revascularization. However, 
simple replantation of a totally amputated ear poses risks of 
complications such as partial or complete composite tissue loss 
due to poor perfusion. With advances in adjunctive postopera-
tive treatments, such as hyperbaric oxygen therapy (HBOT), 
aspirin, prostaglandin, dextran-40, and the application of leech-
es, reports have described improved survival in cases of near-
complete ear amputation in which the ear was attached by a 
narrow skin bridge. However, in cases of complete amputation, 
it is rare for the ear to be salvaged without microvascular recon-
struction. This report presents a case of nonmicrosurgical sal-
vage of a completely amputated ear with local HBOT, platelet-
rich plasma (PRP) injections, and polydeoxyribonucleotide 
(PDRN) injections. 
CASE 
This study was reviewed and approved by the Yonsei University 
Medical Center Institutional Review Board (no. 201510026). 
The informed consent was waived.
A 76-year-old man presented to the emergency center approxi-
mately 1 hour after experiencing total left ear amputation. The 
Salvage of Unilateral Complete Ear Amputation 
with Continuous Local Hyperbaric Oxygen, 
Platelet-Rich Plasma and Polydeoxyribonucleotide 
without Micro-Revascularization
Sang Keon Lee, Yoon Min Lim, Dae Hyun Lew, Seung Yong Song
Institute for Human Tissue Restoration, Department of Plastic and Reconstructive Surgery, Severance Hospital, Yonsei University College of 
Medicine, Seoul, Korea
In many cases of complete ear amputation, microvascular surgery is required for tissue 
perfusion and organ survival. However, microvascular reconstruction is not always feasible in 
the absence of suitable vessels. Here, we present the case of a 76-year-old man who underwent 
complete amputation of the left ear after a collapse at home because of cardiogenic syncope. 
He was treated with primary replantation and underwent a postoperative salvage course 
including continuous local hyperbaric oxygen therapy (HBOT), platelet-rich plasma (PRP) 
injections, and polydeoxyribonucleotide (PDRN) injections. The ear was almost completely 
salvaged, with a tiny eschar at the mid-scapha on both the anterior and posterior aspects. This 
case demonstrates the efficacy of local HBOT with PRP and PDRN injections.
Keywords Replantation / Salvage therapy / Hyperbaric oxygenation / Platelet rich plasma / 
Polydeoxyribonucleotide
Correspondence: Seungyong Song
Department of Plastic and 
Reconstructive Surgery, Yonsei 
University College of Medicine,  
50 Yonsei-ro, Seodaemun-gu,  
Seoul 03722, Korea
Tel: +82-2-2228-2225
Fax: +82-2-393-6947
E-mail: pssysong@yuhs.ac
Received: 3 Mar 2017 • Revised: 25 May 2017 • Accepted: 31 May 2017
pISSN: 2234-6163 • eISSN: 2234-6171 • https://doi.org/10.5999/aps.2017.00451 • Arch Plast Surg 2017;44:554-558
Vol. 44 / No. 6 / November 2017
555
injury was sustained when the patient collapsed in his home be-
cause of cardiogenic syncope, which he had experienced several 
times before. Fortunately, he had placed the amputated ear in a 
saline-filled plastic container. On physical examination under 
local anesthesia, the left ear was sagittally cut through the mid-
portion of the pinna, including most of the scapha and the en-
tire concha (Fig. 1), and proper vessels for microsurgical revas-
cularization (with a caliber of > 0.5 mm) were not seen in either 
the amputated ear or the cut portion of the ear. After informing 
the patient about the possibility of partial or total loss of a com-
posite graft, the decision was made to attempt replantation with 
the planned postoperative salvage technique of continuous local 
HBOT. The amputated ear was minimally debrided and reat-
tached to the original anatomical location as precisely as possi-
ble. A 4-0 Vicryl suture was used to attach the amputated carti-
lage to the cartilage near the external auditory canal, and a 5-0 
Vicryl suture was used to attach the subcutaneous layer of the 
amputated pinna. Meticulous 6-0 interrupted nylon sutures 
were then used to close the skin. After replantation, a gauze ball 
was packed into the ear canal, and the replanted ear was covered 
with a disposable paper cup for continuous local HBOT, instead 
of a specialized device (Fig. 2). The tailored-cut disposable pa-
per cup was fixed to the skin surrounding the ear with surgical 
drape (Ioban 2, 3M, Hutchinson, Kansas, MO, USA) and the 
open-top area was covered with a transparent dressing material 
(Tegaderm film, 3M, Hutchinson) to prevent oxygen leakage. 
Finally, 100% oxygen from a generator was supplied to the paper 
cup chamber at 2 L/min through a rubber tube. The positive 
pressure of oxygen on the replanted ear could be confirmed by 
bulging of the Tegaderm film that covered the paper cup cham-
ber. The paper cup chamber with a surgical drape was replaced 
every 2 days to prevent the inevitable leakage caused by the 
pressure-induced detachment of the chamber from the skin. 
This continuous local HBOT began immediately after replanta-
tion and was continued for 24 hours a day. The patient was 
maintained on this HBOT regimen until 5 days before dis-
charge, and had a total hospital stay of 19 days. On postopera-
tive day (POD) 2, venous congestion of the whole replanted 
pinna was observed, and PRP and PDRN injections were initi-
ated to increase tissue perfusion in the composite graft (Fig. 3). 
PRP was prepared by the following method: 30 mL of venous 
blood was drawn in acid citrate dextrose tubes, and then centri-
fuged at 150 × g for 15 minutes (the first spin). After discarding 
the lower portion corresponding to red blood cells, the superna-
tant was centrifuged again at 400 × g for 10 minutes (the second 
spin). Then, the lowest portion of corresponding platelet pellets 
was mixed with 1.5 mL of supernatant, making 2 mL of PRP. Fi-
Left ear was sagittally cut 
completely through the 
mid portion of the pinna.
Fig. 1. The completely amputated left ear preoperatively
Fig. 2. Immediate postoperative photographs of the replanted ear 
(A) Anterolateral view. (B) Poste-
rior view. (C) Paper cup for local 
hyperbaric oxygen therapy.
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nally, 1 mL of 3% calcium chloride was added to the PRP to in-
duce platelet activation. In addition, 3 mL of PRP was injected 
into the intact ear near the injury site (at 3 points, 1 mL at each 
point, 1 cm apart) every 3 days for 9 days, whereas PDRN (Pla-
centex Integro, Mastelli Srl, Sanremo, Italy) was injected as 1 
ample dose (3 mL, 5.625 mg) on the replanted ear at 6 points 
evenly, every 2 days for 10 days. Marked improvement was seen 
by POD 9. On POD 14, the almost complete survival of the 
composite ear graft was observed, with 2 small areas of eschar 
on the mid-anterior scapha and the direct opposite side. Anti-
bacterial ointment was applied to the eschar and it healed by 
secondary intention. On POD 18, exfoliation was found on the 
anterior and posterior mid-scapha where necrosis had previous-
ly been noted, and viable tissue was observed. The patient was 
discharged on POD 19 with instructions to maintain a sufficient 
application of antibiotic ointment to the wound. On POD 53, 
the ear was almost completely healed, with a tiny eschar at the 
mid-scapha in both the anterior and posterior aspects (Fig. 4). 
DISCUSSION
Few reports have described the salvage of total ear amputation 
with nonmicrosurgical revascularization [1]. Here, we present a 
case in which it was possible to salvage and replant a completely 
amputated ear without micro-reanastomosis by implementing a 
postoperative salvage course including continuous local HBOT, 
PRP injections, and PDRN injections. In particular, PRP and 
PDRN injections have not been described in any previous re-
ports of ear amputation cases. 
Systemic HBOT has already been established as an adjunctive 
treatment to composite grafts for improving and supporting 
ischemic wounds [1,2], and Thom [3] described the mecha-
nism of HBOT, reporting that HBOT increased cellular oxygen 
levels, which, in turn, increased the generation of reactive oxy-
gen species and reactive nitrogen species, which served as sig-
naling molecules in both angiogenesis and protection of isch-
emia-reperfusion injury pathways. Furthermore, based on these 
findings regarding HBOT, studies on local HBOT also have 
been conducted in animal models, and reports showing its effi-
cacy have been published [4,5]. We used a disposable paper cup 
to create a local chamber for supporting hyperbaric oxygen con-
tinuously, at the rate of 2 L/min, for 24 hours a day (Fig. 2). Al-
though it is not clear exactly what the atmospheric pressure was, 
we could confirm that a constant positive pressure was applied 
through a certain degree of bulging of the chamber lid, which 
was covered with Tegaderm. Although a certain amount of oxy-
gen outflow was inevitable, the positive pressure could be main-
tained because the inflow more than compensated for the leak-
age. That is why we supplied 2 L of oxygen per minute. If a small 
amount of oxygen is introduced per minute, it is difficult to ob-
tain sufficient positive pressure. On the other hand, if the amount 
of oxygen introduced per minute is too high, it is difficult to 
keep the chamber stable because of the high pressure. Although 
precise measurements and determinations of atmospheric pres-
sure should be made in further studies, we believe that this tech-
nique supplied enough hyperbaric oxygen for the amputated ear 
to undergo neovascularization, and are confident that this infor-
mation will be clinically helpful. 
PRP injections for improving composite graft survival have 
been reported in rabbit models [6]. Jeon et al. [6] demonstrated 
(A) Lateral view. (B) Posterior view. (A) Anterolateral view. (B) Posterior view.
Fig. 3. Postoperative day 2 photographs Fig. 4. Postoperative day 53 photographs 
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significant increases in vascular endothelial growth factor 
(VEGF) expression in a PRP group compared with a control 
group (non-PRP injection). VEGF has already been reported to 
affect flap survival by promoting angiogenesis in a rat skin mod-
el [7], and it is considered that jointly with other growth factors 
such as fibroblast growth factor and platelet-derived growth fac-
tor stored in PRP, VEGF induces endothelial proliferation and 
neovascularization, thereby enhancing the blood supply of a 
composite graft. Therefore, the PRP injections are expected to 
have played an important role in improving the composite graft 
viability in this case. Moreover, research in other medical fields 
has established amounts of PRP that are clinically used in skin 
rejuvenation, hip or knee osteoarthritis, and tendinopathy [8-
10]. However, no established data exist regarding the amount of 
PRP that should be used in flap injections, so the dose that we 
used in this case was based on the doses used in other clinical 
contexts. 
PDRN is an adenosine A2 agonist that also induces VEGF 
and has been established to have multiple vascular actions, such 
as angiogenesis, in conditions of low tissue perfusion [11]. In 
the process of taking-up of composite grafts, inadequate tissue 
perfusion and ischemia-reperfusion injury are critical factors 
determining graft survival. The protective effect of VEGF on 
ischemia-reperfusion injury has been well established in trans-
plantation surgery, such as kidney, lung and liver procedures 
[11-13], and those reports stated that VEGF affected endotheli-
al cell survival, regulating their proliferation, regeneration, and 
apoptosis. Therefore, we expect that PDRN has the potential to 
improve the survival of composite grafts, enhancing neovascu-
larization and protecting against ischemia-reperfusion injury by 
mediating an increase in VEGF. Lee et al. [14] likewise reported 
that PDRN injection increased VEGF expression in a rat skin 
flap model, and Kim et al. [15] reported that PDRN affected 
the healing process of chronic wounds, and introduced the 
quantity to be injected into the soft tissue that we used in our 
case. 
In traumatic ear amputation, if microvascular anastomosis is 
considered difficult, the best treatment choice is usually delayed 
reconstruction with costal cartilage following primary closure, 
rather than simple replantation, due to the risk of loss of the 
composite graft. However, we propose an alternative method to 
the microvascular reconstruction of a completely amputated ear 
in the absence of suitable vessels, by using an immediate postop-
erative salvage course including continuous local HBOT, PRP 
injections, and PDRN injections, which support the marginally 
perfused composite graft through neovascularization and pro-
tect against ischemia-reperfusion injury. Although all these sal-
vage techniques have been used in animal experiments, the rele-
vant studies include poorly controlled samples, and no consen-
sus exists regarding postoperative salvage care, the unexpectedly 
good cosmetic results in this case suggest that continuous local 
HBOT with PRP and PDRN injections may play a role in in-
creasing the survival of composite grafts. To demonstrate the ef-
ficacy of these adjuvant salvage management methods, further 
prospective clinical studies should be conducted.
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